Clinical Trial Update: Optimizing Response in Psychosis Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an Optimizing Response in Psychosis study indicates the trial was terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder Not Otherwise Specified
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: TERMINATED | Results posted: 2015-04-29